Administration by insulin syringe is recommended. Due to the low volumes involved, care should be taken when administering this product. Temvet Injection should be administered twice; once as part of premedication and once at wound closure.
Cats. Give 20 microgram/kg bodyweight (0.067 mL/kg bodyweight) by intramuscular or intravenous injection. The first (premedication) dose should be administered approximately 30 minutes before anaesthetic induction. A second dose should be administered one to two hours later (at wound closure).
Animals administered opioids with sedative and analgesic properties may show variable responses. Therefore, the response of individual animals should be monitored and subsequent doses should be adjusted accordingly. In some cases, repeat doses may fail to provide additional analgesia; in such cases, consideration should be given to using a suitable injectable nonsteroidal anti-inflammatory drug. Use of buprenorphine in conjunction with other centrally acting agents such as acepromazine, medetomidine or inhalation anaesthetics, may enable the dose of these agents to be reduced.
Do not administer by the intrathecal or peridural route. Do not use preoperatively for caesarean section.
